Frier Levitt partner Edgar Asebey has been interviewed by Pharmacy Times in, “Pharmacists’ Role in Translating FDA’s New Direct-to-Consumer Advertising Rules.” In this discussion, Edgar explains the FDA’s renewed efforts to strengthen oversight of direct-to-consumer (DTC) pharmaceutical advertising, and the vital role pharmacists can play in this evolving landscape.
While most pharmaceutical companies have followed existing standards, enforcement has often been inconsistent, particularly regarding requirements for plain-language communication, balanced audio and text, proper text visibility, and the avoidance of distracting visuals. As the FDA works to modernize its rules and enhance compliance, Edgar highlights that pharmacists are uniquely positioned to bridge the gap between advertising and understanding. This is crucial in helping patients interpret risks and benefits more accurately and make informed, evidence-based healthcare decisions.
Watch or read the interview here: https://www.pharmacytimes.com/view/pharmacists-role-in-translating-fda-s-new-direct-to-consumer-advertising-rules
